Eric Shen

Nessuna posizione attualmente

Finance

Health Technology

Consumer Services

Profilo

Eric Shen worked as a Director of Corporate Development & Operations at Kojin Therapeutics, Inc. from 2021 to 2023.
He also worked as a Managing Director at Old Silver VC LLC in 2021.
Mr. Shen received his undergraduate degree from Brandeis University in 2016.

Precedenti posizioni note di Eric Shen

Società	Posizione	Fine
Kojin Therapeutics, Inc. Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States.	Investitore di Private Equity	01/11/2023
Old Silver VC LLC Old Silver VC LLC Investment ManagersFinance Old Silver VC LLC (Old Silver VC) is a venture capital firm founded in 2020. The firm is headquartered in Boston, Massachusetts.	Investitore di Private Equity	01/09/2021

Vedi nel dettaglio l'esperienza di Eric Shen

Formazione di Eric Shen

Brandeis University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Eric Shen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Old Silver VC LLC Old Silver VC LLC Investment ManagersFinance Old Silver VC LLC (Old Silver VC) is a venture capital firm founded in 2020. The firm is headquartered in Boston, Massachusetts.	Finance
Kojin Therapeutics, Inc. Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States.	Health Technology